VJHemOnc is committed to improving our service to you

iwCLL 2019 | Evaluating acalabrutinib in CLL treatment

VJHemOnc is committed to improving our service to you

Jennifer Woyach

Jennifer Woyach, MD, Ohio State University College of Medicine, Columbus, OH, evaluates the use of acalabrutinib in chronic lymphocytic leukemia (CLL) treatment, in comparison to other therapies. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter